Literature DB >> 21398575

Platelet activation by collagen provides sustained release of anabolic cytokines.

Sophia Harrison1, Patrick Vavken, Sherwin Kevy, May Jacobson, David Zurakowski, Martha M Murray.   

Abstract

BACKGROUND: Platelet-rich plasma (PRP) has been increasingly used in sports medicine applications. Platelets are thought to release growth factors important in wound healing, including transforming growth factor (TGF-β1), platelet-derived growth factor (PDGF-AB), and vascular endothelial growth factor (VEGF). However, little is known about the effect of platelet activator choice on growth factor release kinetics. HYPOTHESIS: The choice of platelet activator would affect the timing and level of growth factor release from PRP. STUDY
DESIGN: Controlled laboratory study.
METHODS: Platelet-rich plasma aliquots were activated with either thrombin or collagen. A control group of whole blood aliquots was clotted with thrombin. Supernatant containing the released growth factors was collected daily for 1 week. Levels of TGF-β1, PDGF-AB, and VEGF were measured using enzyme-linked immunosorbent assay (ELISA).
RESULTS: The use of thrombin as an activator resulted in immediate release of TGF-β1 and PDGF-AB, while the collagen-activated PRP clots released similar amounts each day for 5 days. The use of collagen as an activator resulted in an 80% greater cumulative release of TGF-β1 from the PRP aliquots over 7 days (P < .001). Concentrating platelets to 3 times the systemic blood level resulted in a 3-fold higher release of TGF-β1, 2.5-fold greater release of PDGF, and 5-fold greater release of VEGF (all P < .0001) when compared with whole blood control clots, but no significant differences in the timing of release were noted.
CONCLUSION: These experiments demonstrated that the choice of platelet activator can significantly influence the release kinetics of cytokines from PRP, with thrombin resulting in an immediate release and collagen having a more sustained release pattern. CLINICAL RELEVANCE: The level and rate of growth factor release depends on the selected platelet activator, a factor that should be considered when selecting a PRP system for a given application.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398575      PMCID: PMC3176726          DOI: 10.1177/0363546511401576

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  37 in total

1.  Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro.

Authors:  H J Nielsen; K Werther; T Mynster; M N Svendsen; S Rosendahl; T Elley; F Skov
Journal:  Vox Sang       Date:  2001-04       Impact factor: 2.144

Review 2.  Fibrin sealants in surgical practice: An overview.

Authors:  M R Jackson
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

Review 3.  Biomedical applications of collagen.

Authors:  C H Lee; A Singla; Y Lee
Journal:  Int J Pharm       Date:  2001-06-19       Impact factor: 5.875

Review 4.  Autologous platelets as a source of proteins for healing and tissue regeneration.

Authors:  Eduardo Anitua; Isabel Andia; Bruno Ardanza; Paquita Nurden; Alan T Nurden
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

Review 5.  Regulation of wound healing by growth factors and cytokines.

Authors:  Sabine Werner; Richard Grose
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 6.  Fibrin sealants in clinical practice.

Authors:  David M Albala
Journal:  Cardiovasc Surg       Date:  2003-08

7.  Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up.

Authors:  Joost C Peerbooms; Jordi Sluimer; Daniël J Bruijn; Taco Gosens
Journal:  Am J Sports Med       Date:  2010-02       Impact factor: 6.202

8.  Soluble vascular endothelial growth factor in various blood transfusion components.

Authors:  H J Nielsen; K Werther; T Mynster; N Brünner
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

Review 9.  Thrombin and platelet activation.

Authors:  Lawrence F Brass
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

10.  Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count.

Authors:  Gernot Weibrich; Wilfried K G Kleis; Gerd Hafner; Walter E Hitzler
Journal:  J Craniomaxillofac Surg       Date:  2002-04       Impact factor: 2.078

View more
  52 in total

1.  Peripheral blood mononuclear cells enhance the anabolic effects of platelet-rich plasma on anterior cruciate ligament fibroblasts.

Authors:  Ryu Yoshida; Martha M Murray
Journal:  J Orthop Res       Date:  2012-07-05       Impact factor: 3.494

Review 2.  Ultrasound-guided procedures to treat sport-related muscle injuries.

Authors:  Davide Orlandi; Angelo Corazza; Alice Arcidiacono; Carmelo Messina; Giovanni Serafini; Luca M Sconfienza; Enzo Silvestri
Journal:  Br J Radiol       Date:  2015-11-12       Impact factor: 3.039

Review 3.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

Review 4.  Radiological interventions for soft tissue injuries in sport.

Authors:  R S D Campbell; A J Dunn
Journal:  Br J Radiol       Date:  2012-05-02       Impact factor: 3.039

Review 5.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

6.  The role of platelet-rich plasma in inducing musculoskeletal tissue healing.

Authors:  Brian C Halpern; Salma Chaudhury; Scott A Rodeo
Journal:  HSS J       Date:  2012-01-18

7.  2011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues.

Authors:  Scott A Rodeo; Scott D Boden; Martha M Murray; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2013-08-07       Impact factor: 5.284

8.  Increasing platelet concentration in platelet-rich plasma inhibits anterior cruciate ligament cell function in three-dimensional culture.

Authors:  Ryu Yoshida; Mingyu Cheng; Martha M Murray
Journal:  J Orthop Res       Date:  2013-10-04       Impact factor: 3.494

Review 9.  Growth factor delivery vehicles for tendon injuries: Mesenchymal stem cells and Platelet Rich Plasma.

Authors:  Alberto Guevara-Alvarez; Andreas Schmitt; Ryan P Russell; Andreas B Imhoff; Stefan Buchmann
Journal:  Muscles Ligaments Tendons J       Date:  2014-11-17

Review 10.  Bridge-enhanced ACL repair: A review of the science and the pathway through FDA investigational device approval.

Authors:  Benedikt L Proffen; Gabriel S Perrone; Gordon Roberts; Martha M Murray
Journal:  Ann Biomed Eng       Date:  2015-01-29       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.